人民财讯8月21日电，太极集团（600129）8月21日晚间披露2025年半年度报告，上半年实现营业收入 56.58亿元，同比下降27.63%；归母净利润1.39亿元，同比下降71.94%；基本每股收益0.25元。净利润同 比下降主要受相关政策以及部分产品社会库存持续消化等因素影响，营业收入较上年同期减少。 ...

Group 1 - The core viewpoint of the article highlights the decline in the production of traditional Chinese medicine (TCM) in China, with a projected decrease in output and significant year-on-year reductions [1][3] - According to data from the National Bureau of Statistics, the production of TCM in China is expected to be 156,000 tons by June 2025, representing a year-on-year decrease of 6.6% [1] - In the first half of 2025, the cumulative production of TCM in China reached 875,000 tons, showing a cumulative decline of 13% [1] Group 2 - The article lists several publicly listed companies in the TCM sector, including Yunnan Baiyao, Tongrentang, and others, indicating the key players in the industry [1] - The report referenced is the "2025-2031 China Traditional Chinese Medicine Industry Development Situation Analysis and Industry Prospect Planning Report" published by Zhiyan Consulting, which provides insights into the future of the TCM industry [1][2]

Industry Overview - The number of registered companies in China's Ejiao industry has shown a growth trend, with over 600 companies registered as of June 2025, and nearly 200 new companies added between 2016 and 2020 [1][3] - The production of Ejiao blocks in China is projected to increase, with an estimated production of 4,379 tons in 2024 [3] Supply Situation - The sales-to-production ratio of Dong'e Ejiao has been declining over the past three years, dropping from 100.9% in 2022 to 97.9% in 2024, indicating increased inventory pressure [5] Demand Scale - The market size of the Ejiao industry in China is expected to reach approximately 29.1 billion yuan in 2024, driven by rising disposable income and increased health awareness among consumers [7] Price Trends - The prices of Ejiao products from major brands like Dong'e Ejiao and Fupai Ejiao have remained stable, with Dong'e Ejiao priced at 2,700 yuan per kilogram and Fupai Ejiao at approximately 1,260 yuan per kilogram [9]

Core Viewpoint - The company, Chongqing Taiji Industrial (Group) Co., Ltd., is selling idle real estate assets to optimize its asset structure and improve asset utilization, with a transaction price of 25.8498 million yuan [2][4]. Group 1: Transaction Overview - The company plans to sell an idle property located at No. 6, Xin Nan Road, Yubei District, Chongqing, through public listing [2][4]. - The transaction does not constitute a related party transaction or a major asset restructuring [3][4]. Group 2: Asset Details - The property has a building area of 820.63 square meters and a land use area of 1,951 square meters, with a registered purpose as a complete residential unit [5]. - The property is free from any mortgages, pledges, or third-party rights, and there are no significant disputes or judicial measures against it [5]. Group 3: Valuation and Pricing - The asset was appraised by Chongqing Huifeng Real Estate and Land Asset Appraisal Co., Ltd., with a market value of 25.8498 million yuan as of March 31, 2025 [6][7]. - The original book value of the asset was 9.3125 million yuan, with a net book value of 4.2785 million yuan, resulting in an appraisal increment of 21.5713 million yuan and an increase rate of 504.18% [8]. Group 4: Transaction Impact - The sale is expected to enhance the company's asset operation efficiency and will contribute approximately 18 million yuan to the company's financial results for 2025 [14].

Core Viewpoint - Taiji Group has received a loan commitment from China Merchants Bank's Chongqing branch for a stock repurchase program, indicating the company's strategic move to enhance shareholder value through buybacks [2] Group 1 - The loan commitment amount is up to 108 million yuan, which is not more than 90% of the actual amount used for the repurchase [2] - The financing term for the loan is set at 3 years [2] - The specific details of the loan will be formalized in a loan contract between the parties [2]

二、收到股份回购贷款承诺函的具体情况 近日，公司收到招商银行股份有限公司重庆分行出具的《贷款承 诺函》，主要内容如下： 证券代码：600129 证券简称：太极集团 公告编号：2025-061 重庆太极实业（集团）股份有限公司 关于取得金融机构股票回购贷款承诺函的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 一、本次回购股份方案的基本情况 重庆太极实业（集团）股份有限公司（以下简称"公司"）于 2025 年 7 月 16 日、8 月 6 日召开了第十届董事会第三十次会议、2025 年第二次临时股东大会，审议通过了<关于以集中竞价交易方式回购 公司股份预案>的议案。公司拟使用自有资金或自筹资金，通过集中 竞价交易方式回购公司人民币普通股 A 股，回购股份的资金总额为不 低于人民币8,000.00万元（含）且不超过人民币12,000.00万元（含）， 回购股份的价格为不超过 28.03 元/股（含），回购股份将全部用于 注销并减少公司注册资本，回购股份的实施期限为自公司股东大会审 议通过本次回购方案之日起 12 个月 ...

证券代码：600129 证券简称：太极集团 公告编号：2025-060 重庆太极实业（集团）股份有限公司 关于出售闲置资产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 重要内容提示： 1.交易简要内容:重庆太极实业（集团）股份有限公司(以下简称： 公司)将公司位于重庆市渝北区新南路 6 号附 6 号 1 幢 1-1 闲置房产 通过公开挂牌方式出售，交易价格为 2,584.98 万元。 2.本次交易不构成关联交易 面积：建筑面积为 820.63 平方米，土地使用权面积为 1951 平方 米 证载用途：成套住宅 3.本次交易不构成重大资产重组 4.本次闲置房产已履行相关审批报备手续，无需提交董事会和公 司股东大会审议。 一、交易概述 为聚焦医药主业，盘活闲置资产，优化资产结构，提高公司资产 利用率，公司拟出售位于重庆市渝北区新南路 6 号附 6 号 1 幢 1-1 房 产。该事项已经公司总经理办公会审议通过，同意上述房产以评估价 值 2,584.98 万元在产权交易所对外公开挂牌出售。 根据《上海证券交易所股票上市 ...

Core Viewpoint - Taiji Group announced the sale of idle property in Chongqing for 25.8498 million yuan, aiming to enhance asset efficiency and align with business development needs [1] Summary by Relevant Sections Asset Sale - The company will sell an idle property located at No. 6, Xinnan Road, Yubei District, Chongqing through public listing [1] - The transaction price is set at 25.8498 million yuan [1] Financial Impact - The proceeds from the sale are expected to be approximately 18 million yuan, which will positively impact the company's financial status and operational performance [1] - The income from this asset disposal will be recorded in the company's 2025 financial results [1]

Group 1 - The company, Taiji Group (600129), announced on August 14 that it has received a loan commitment letter from China Merchants Bank's Chongqing branch, with a loan commitment amount not exceeding 108 million yuan [1] - The financing term for the loan is set at 3 years, and the purpose of the loan is designated for stock repurchase [1]

Core Viewpoint - Taiji Group (600129.SH) has acknowledged the recent notification from the National Health Commission and the National Administration of Traditional Chinese Medicine regarding the treatment plan for Chikungunya fever, highlighting the lack of specific treatment methods and the focus on symptomatic support [1] Group 1 - Chikungunya fever is an acute infectious disease caused by the Chikungunya virus, transmitted by mosquito bites, characterized by fever, joint pain, and rash [1] - Current treatment methods are primarily supportive, including fever reduction and physical cooling, with recommendations for using acetaminophen for persistent high fever [1] - The company’s subsidiary, Southwest Pharmaceutical Co., produces a medication called Sanlietong (generic name: Compound Acetaminophen Tablets II), which is suitable for alleviating fever caused by colds or flu, as well as various pain symptoms such as headaches, toothaches, and joint pain [1]